The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-(4-Cyclohexylpiperazin-1-yl)butyl)-3,4-dihydroquinolin-2(1H)-one ID: ALA4581662
PubChem CID: 155561628
Max Phase: Preclinical
Molecular Formula: C23H35N3O
Molecular Weight: 369.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1CCc2ccccc2N1CCCCN1CCN(C2CCCCC2)CC1
Standard InChI: InChI=1S/C23H35N3O/c27-23-13-12-20-8-4-5-11-22(20)26(23)15-7-6-14-24-16-18-25(19-17-24)21-9-2-1-3-10-21/h4-5,8,11,21H,1-3,6-7,9-10,12-19H2
Standard InChI Key: HZVGBWBVVRIGJW-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
27.8656 -19.5461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8745 -20.8280 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.5864 -20.4075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3050 -20.8128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0153 -20.3931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7338 -20.7984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4440 -20.3788 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1600 -20.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1457 -19.1405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4314 -19.5584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8670 -20.3722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1584 -20.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4486 -20.8383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4525 -21.6656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1524 -19.5963 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.8887 -21.6553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1737 -22.0720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1780 -22.8978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8968 -23.3078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6125 -22.8860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6047 -22.0616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5775 -19.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2945 -19.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0065 -19.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0015 -18.2958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2846 -17.8876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5726 -18.3044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
7 10 1 0
8 11 1 0
1 9 1 0
9 10 1 0
1 11 1 0
2 12 1 0
2 16 1 0
12 13 1 0
13 14 1 0
14 17 1 0
12 15 2 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
1 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 369.55Molecular Weight (Monoisotopic): 369.2780AlogP: 3.70#Rotatable Bonds: 6Polar Surface Area: 26.79Molecular Species: BASEHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.02CX LogP: 3.62CX LogD: 2.00Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.72Np Likeness Score: -1.11
References 1. Zampieri D, Fortuna S, Calabretti A, Romano M, Menegazzi R, Schepmann D, Wünsch B, Collina S, Zanon D, Mamolo MG.. (2019) Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents., 180 [PMID:31319263 ] [10.1016/j.ejmech.2019.07.012 ]